Niagen Bioscience, Inc. (NAGE) Tops Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts NAGE Hot Sheet
Join SI Premium – FREE
Niagen Bioscience, Inc. (NASDAQ: NAGE) reported Q1 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $27.07 million.
For earnings history and earnings-related data on Niagen Bioscience, Inc. (NAGE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Brookfield prices $600M senior notes at 5.65% due 2031
- Lilly breaks ground on $6.5B Houston drug manufacturing site
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
